A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)

NCT01822483 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Mycophenolate sodium
DRUG: Mycophenolate mofetil

Sponsor

Irmandade Santa Casa de Misericórdia de Porto Alegre

Collaborators

[object Object]